Cydney Nichols

629 total citations
16 papers, 495 citations indexed

About

Cydney Nichols is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Cydney Nichols has authored 16 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Cydney Nichols's work include Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Cydney Nichols is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Cydney Nichols collaborates with scholars based in United States and China. Cydney Nichols's co-authors include Yong‐Mi Kim, Hye Na Kim, James R. Berenson, Eun Ji Gang, Haiming Chen, Mingjie Li, Eric Sanchez, Ralph V. Boccia, Benjamin Bonavida and Gabriel N. Waterman and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Cydney Nichols

15 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cydney Nichols United States 7 226 186 175 112 106 16 495
Heather Kostner United States 7 413 1.8× 263 1.4× 107 0.6× 102 0.9× 208 2.0× 12 624
Ján Gurský Czechia 13 137 0.6× 271 1.5× 55 0.3× 39 0.3× 36 0.3× 22 466
Timothy M. Pierpont United States 6 145 0.6× 132 0.7× 29 0.2× 117 1.0× 75 0.7× 10 376
George Giotopoulos United Kingdom 14 78 0.3× 453 2.4× 254 1.5× 40 0.4× 93 0.9× 24 678
Sarah May United States 7 53 0.2× 90 0.5× 76 0.4× 78 0.7× 15 0.1× 9 338
Laura Dezza Italy 16 128 0.6× 222 1.2× 366 2.1× 82 0.7× 28 0.3× 29 672
Taina Turpeenniemi-Hujanen Finland 8 323 1.4× 266 1.4× 57 0.3× 43 0.4× 19 0.2× 9 583
Dan Costin United States 7 297 1.3× 202 1.1× 40 0.2× 101 0.9× 19 0.2× 21 559
Krista Fager United States 8 135 0.6× 113 0.6× 161 0.9× 31 0.3× 69 0.7× 11 374
Y Kanayama Japan 8 72 0.3× 242 1.3× 237 1.4× 192 1.7× 34 0.3× 9 559

Countries citing papers authored by Cydney Nichols

Since Specialization
Citations

This map shows the geographic impact of Cydney Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cydney Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cydney Nichols more than expected).

Fields of papers citing papers by Cydney Nichols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cydney Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cydney Nichols. The network helps show where Cydney Nichols may publish in the future.

Co-authorship network of co-authors of Cydney Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Cydney Nichols. A scholar is included among the top collaborators of Cydney Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cydney Nichols. Cydney Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Kim, Hye Na, et al.. (2022). PI3K Targeting in Non-solid Cancer. Current topics in microbiology and immunology. 436. 393–407. 4 indexed citations
3.
Ruan, Yongsheng, Hye Na Kim, Heather Ogana, et al.. (2021). Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology. 11. 766888–766888. 2 indexed citations
4.
Nichols, Cydney, et al.. (2019). Targeting PI3K Signaling in Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 20(2). 412–412. 62 indexed citations
5.
Robinson, Hannah R., Junpeng Qi, Erika M. Cook, et al.. (2018). A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood. 132(5). 521–532. 89 indexed citations
6.
Kim, Hye Na, et al.. (2018). Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy. Blood. 132(Supplement 1). 1420–1420. 2 indexed citations
7.
Saba, Nakhle S., Deanna H. Wong, Patricia Lobelle‐Rich, et al.. (2017). MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. Cancer Research. 77(24). 7038–7048. 40 indexed citations
8.
Lillo, Mauricio A., Cydney Nichols, Tiffany N. Seagroves, Gustavo A. Miranda‐Carboni, & Susan A. Krum. (2017). Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells. Hormones and Cancer. 8(2). 90–99. 22 indexed citations
9.
Lillo, Mauricio A., Cydney Nichols, Raisa I. Krutilina, et al.. (2016). Methylparaben stimulates tumor initiating cells in ER+ breast cancer models. Journal of Applied Toxicology. 37(4). 417–425. 44 indexed citations
10.
Nichols, Cydney, Xiangming Ding, Gustavo A. Miranda‐Carboni, & Susan A. Krum. (2014). Abstract 3192: The environmental estrogen bisphenol A (BPA) regulates mammary gland stem cells. Cancer Research. 74(19_Supplement). 3192–3192. 2 indexed citations
11.
Sanchez, Eric, Mingjie Li, Cathy Wang, et al.. (2012). Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206. Clinical Cancer Research. 18(14). 3856–3867. 14 indexed citations
12.
Sanchez, Eric, Mingjie Li, Jennifer Li, et al.. (2012). Serum B‐cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. British Journal of Haematology. 158(6). 727–738. 210 indexed citations
13.
Sanchez, Eric, Cydney Nichols, Mingjie Li, et al.. (2011). Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206. Blood. 118(21). 5107–5107. 1 indexed citations
14.
Li, Mingjie, David A. Gutierrez, Cydney Nichols, et al.. (2011). TRAF6 Dominant Negative Peptides Block Intracellular Signaling Resulting in Anti-Myeloma and Anti-Bone Resorptive Effects in Multiple Myeloma. Blood. 118(21). 2919–2919. 1 indexed citations
15.
Sanchez, Eric, Cydney Nichols, Mingjie Li, et al.. (2011). Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM). Blood. 118(21). 2946–2946. 1 indexed citations
16.
Li, Zhiwei, Eric Sanchez, Cathy Wang, et al.. (2010). Synergistic Anti-Myeloma Effects of the Lyn Kinase Inhibitor INNO-406 In Combination with Doxorubicin, Melphalan and Bortezomib. Blood. 116(21). 5015–5015. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026